Who are Capstan Therapeutics's investors?

Capstan Therapeutics's investors include Finchley Healthcare Ventures, Pfizer Venture Investments, RA Capital, Sofinnova Ventures, Vida Ventures, Alexandria, Forbion.

How much funding has Capstan Therapeutics raised?

Capstan Therapeutics has disclosed $227M raised across 3 rounds.

Where is Capstan Therapeutics headquartered?

Capstan Therapeutics is headquartered in San Diego, US.

Capstan Therapeutics

San Diego, US · Founded 2020 · Delaware corporation · 7 known investors

Find your way into Capstan Therapeutics

Paths you didn't know you had: your email and LinkedIn already hold routes to the Capstan Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

AbbVie is a biopharmaceutical company that discovers and delivers medicines for immune-mediated diseases and other therapeutic areas globally.

Biotech Healthtech Medical Devices

Founders & leadership

Adrian BotExecutiveVenture Partner at RA Capital

Laura ShawverExecutive

Ramin Farzaneh-Far ExecutiveRamin Farzaneh-Far is an executive officer at Capstan Therapeutics with expertise in clinical trial design and implementation, early and late stage clinical development, translational research, business development, and corporate strategy.

Justin ThackerNamed on SEC filing

Karen SmithNamed on SEC filing

Fabio PucciNamed on SEC filing

Michal SilverbergNamed on SEC filing

Michael BaranNamed on SEC filing

Rajul Jain Named on SEC filingManaging Director at Vida Ventures

Board

Nandita Shangari Board directorManaging Director at RA Capital

Nanna LuneborgBoard director

Erez ChimovitsBoard director

Investors · 7

Finchley Healthcare Ventureslisted by Finchley Healthcare VenturesMontreal

How we know: Finchley Healthcare Ventures's portfolio page · Not right? Tell us

Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M

How we know: Pfizer Venture Investments's portfolio page · Not right? Tell us

RA Capitallisted by RA CapitalBoston

How we know: RA Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Sofinnova Ventureslisted by Sofinnova VenturesMenlo Park · $100K – $15M

How we know: Sofinnova Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

Vida Ventureslisted by Vida VenturesLos Angeles

How we know: Vida Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

AlexandriareportedPasadena

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

ForbionreportedNaarden

How we know: a partner's Signal profile · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$227M disclosed across 3 rounds · 2021–2024

▶$76.5MraisedMar 2024 · 14 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Justin ThackerExecutive Officer
Karen SmithDirector
Fabio PucciDirector
Nandita ShangariDirector
Adrian BotExecutive Officer
Michal SilverbergDirector
Laura ShawverExecutive Officer, Director
Nanna LuneborgDirector
Michael BaranDirector
Erez ChimovitsDirector
Ramin Farzaneh-FarExecutive Officer
Rajul JainDirector
Priya KarmaliExecutive Officer
Athena CountouriotisDirector

Offering amount: $102M
Amount sold: $76.5M
First sale: Jun 2022
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$63MraisedMar 2024 · 9 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Michal SilverbergDirector
Fabio PucciDirector
Ramin Farzaneh-FarExecutive Officer
Rajul JainDirector
Laura ShawverExecutive Officer, Director
Nanna LuneborgDirector
Nandita ShangariDirector
Karen SmithDirector
Justin ThackerExecutive Officer
Adrian BotExecutive Officer
Erez ChimovitsDirector
Priya KarmaliExecutive Officer
Michael BaranDirector
Athena CountouriotisDirector

Offering amount: $63M
Amount sold: $63M
First sale: Nov 2021
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$87.5MraisedMar 2024 · 21 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Fabio PucciDirector
Nandita ShangariDirector
Michal SilverbergDirector
Erez ChimovitsDirector
Athena CountouriotisDirector
Rajul JainDirector
Laura ShawverExecutive Officer, Director
Ramin Farzaneh-FarExecutive Officer
Justin ThackerExecutive Officer
Michael BaranDirector
Adrian BotExecutive Officer
Nanna LuneborgDirector
Priya KarmaliExecutive Officer
Karen SmithDirector

Offering amount: $175M
Amount sold: $87.5M
First sale: Mar 2024
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Capstan Therapeutics Raises $175M in Series B Financingfinsmes.com · Mar 2024

Frequently asked questions

What does Capstan Therapeutics do?: AbbVie is a biopharmaceutical company that discovers and delivers medicines for immune-mediated diseases and other therapeutic areas globally.
Who are Capstan Therapeutics's investors?: Capstan Therapeutics's investors include Finchley Healthcare Ventures, Pfizer Venture Investments, RA Capital, Sofinnova Ventures, Vida Ventures, Alexandria, Forbion.
How much funding has Capstan Therapeutics raised?: Capstan Therapeutics has disclosed $227M raised across 3 rounds.
Where is Capstan Therapeutics headquartered?: Capstan Therapeutics is headquartered in San Diego, US.